A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study

NCT06531499 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-Resistant Prostate Cancer

Interventions

DRUG: AAA617
DRUG: Gonadotropin-releasing hormone (GnRH) analogues
DRUG: Gonadotropin-releasing hormone (GnRH) antagonists

Sponsor

Novartis Pharmaceuticals